Carbonizing proton beam therapy for lung cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210024
- Recipient
-
The General Hospital Corporation UEI FLJ7DQKLL226 Part of Partners Healthcare System Incorporated
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $168,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Boston, MA 02114, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded a $168,000 Project Grant to the Massachusetts General Hospital, a division of Partners Healthcare System Incorporated, to support research on carbonizing proton beam therapy for lung cancer. The grant was awarded on January 1, 2022 under the Military Medical Research and Development program (CFDA 12.420) to transform health care for service members and the public through innovative medical research solutions for battlefield injuries and investigations into medical solutions. The funding will support the awardee's efforts to investigate carbonizing proton beam therapy techniques for lung cancer through June 30, 2023, advancing treatment options through this innovative medical research.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $168,000 |
Quick answers
Who received award W81XWH2210024?
W81XWH2210024 was awarded to The General Hospital Corporation by Defense Health Agency (Department of Defense) on January 1, 2022.
How much is award W81XWH2210024 worth?
$168,000 has been obligated on W81XWH2210024.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award